Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Market share of generics in European countries 2018

Published by Matej Mikulic, Jul 24, 2020
This statistic displays the share of generics in the pharmaceutical market sales value in Europe by selected countries in 2018. The generic share in the pharmaceutical industry's market sales in Denmark exceeded 32 percent in 2018. Market share of generics is higher in newer EU member states due to low levels of intellectual property protection.

Market share of generics in selected European countries as of 2018

Loading statistic...

Additional Information

© Statista 2021

Show source

You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Show sources information
Show publisher information

Release date

2020

Region

Europe

Survey time period

2018

Supplementary notes

EFPIA: European Federation of Pharmaceutical Industries and Associations
Bulgaria, Croatia, Denmark, Estonia, Finland, Greece, Ireland, Hungary, U.K.: share of generics in pharmacy market sales.
Austria, Belgium, France, Germany, Italy, Netherlands, Portugal, Slovenia, Spain: share of generics in reimbursable pharmacy market sales.
Lithuania, Norway, Poland, Romania, Russia, Serbia, Slovakia, Sweden, Switzerland, Turkey: share of generics in total market sales.
Cyprus, Czech Republic, Iceland, Latvia, Malta: 2018 data not available.
France: data relate only to those active substances listed on the official list of medicines.
Definition: ‘generic’ means a medicine based on an active substance that is out of patent and which is marketed under a different name from that of the original branded medicine.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Further Content: You might find this interesting as well

Statistics

Topics

SanofiGlobal pharmaceutical industryTop pharmaceutical drugsPfizerNovartis
Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Menu